CRISPR-Cas9 gene editing revolutionized biological and biomedical research virtually overnight. The versatile tool has been used to improve crop yields and cure previously uncurable conditions like sickle cell anemia. In May 2025, the Nobel Prize-winning technology brought about another major biomedical breakthrough, as Kiran Musunuru and Rebecca Ahrens-Nicklas introduced the first personalized CRISPR gene editing... The post The CRISPR revolution continues appeared first on Cold Spring Harbo...| Cold Spring Harbor Laboratory
Nature writes the best horror stories – In The New York Times’ recent piece, the return of the screwworm, a flesh‑eating parasite once eradicated from the U.S. Indeed, cattle ranchers are once again staring at wounds riddled with maggots. This insect, which devastated cattle in the 20th century, is making a comeback, spurring governments to […] The post From pasture to lab: The new biotech toolkit for cattle appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthori...| Labiotech.eu
In May, patient Michael Kalberer wrote about why he joined a revolutionary clinical trial where he was only the second person in the world to receive CRISPR gene editing inside the body. Michael recently provided an update on how he’s been doing since, and in what ways his vision has changed. In September 2020, Michael… Read More »CRISPR Gene Therapy Update: Seeing a Sunset The post CRISPR Gene Therapy Update: Seeing a Sunset appeared first on FOCUS.| FOCUS
CRISPR-based gene editing technology Casgevy has been approved for treatment of sickle cell disease and beta-thalassaemia in the NHS| Genomics Education Programme
We’re witnessing a groundbreaking shift in the global food system, driven by the Ag Biotech revolution. From bioengineered crops to carbon-sequestering farms, this wave of innovation is making our agriculture more sustainable, resilient, and productive. This post FoodTech Wave 3.0: The Ag Biotech Revolution Transforming Our Food Future appeared first on Forward Fooding - Powering the Food & Food Tech revolution!.| Forward Fooding – Powering the Food & Food Tech revolution!
AI-enabled drug discovery approach identified potentially game-changing treatment, which has been advanced from the lab bench to an FDA Orphan Drug Designation in record time| Wyss InstituteWyss Institute
Dr. Jeannie Lee, a leading expert in epigenetics and gene regulation at Harvard Medical School and Massachusetts General Hospital, has been awarded a Blavatnik Therapeutics Challenge Award, including $1 million in funding, to expand her groundbreaking work on reactivating the The post Harvard’s Dr. Jeannie Lee Wins $1M Award to Develop Gene Reactivation Therapy for Fragile X appeared first on FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome.| FRAXA Research Foundation – Finding a Cure for Fragile X Syndrome
CRISPR gene editing of T cells can be performed using CRISPR as cancer therapy to bypass the inactivation of T cells by cancerous cells.| Bitesize Bio
The following is an excerpt from an article by the NEXT LEVEL: Wem gehört das Leben? – Warum wir Gentechnik stoppen müssen / Who Owns Life? – Why We Must Stop Genetic Engineering. Genetic engineeri…| Critical Check
How a new approach to correcting heterozygous mutations and other novel techniques for gene editing are transforming the potential to combat disease| Pediatrics Nationwide
Investigators from Nationwide Children’s Hospital created fratricide-resistant and metabolically-enhanced chimeric antigen receptor (CAR) natural killer (NK) and T cells that have cytotoxic effects on many hematologic tumors.| Pediatrics Nationwide
Scientists discover new gene editing tools in bacterial "jumping genes" that can be modified to cut, paste, and flip any sequence of DNA.| Singularity Hub
Overriding natural evolution, gene drives could add genes that make weeds more vulnerable to herbicides or reduce their pollination and numbers.| Singularity Hub
Explore 10 gene therapy companies operating within the biotech industry, as each one hopes to develop their own novel candidates.| Labiotech.eu
Using the safe and sensible CRISPR technology that has the power to help the 300,000 babies born with sickle cell disease each year and the nearly 10 million people estimated to suffer from this genetic disorder globally.| science.thewire.in
de Bailey Kirkpatrick, 28 de fevereiro de 2017 *| IERFH